quipazine has been researched along with Anochlesia in 9 studies
Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In electrophysiology studies, acute administration of FMPD selectively elevated the number of spontaneously active A10 (versus A9) dopamine neurons and chronic administration selectively decreased the number of spontaneously active A10 (versus A9) dopamine neurons." | 1.33 | Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine. ( Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR, 2005) |
| "Ziprasidone (CP-88,059) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects in preclinical assays predictive of antipsychotic activity." | 1.29 | Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. ( Guanowsky, V; Howard, HR; Lebel, LA; Lowe, JA; McLean, S; Schmidt, AW; Schulz, DW; Seeger, TF; Seymour, PA; Zorn, SH, 1995) |
| "Perphenazine (5 mg/kg) produced severe catalepsy which lasted for more than 4 hr." | 1.27 | Yohimbine potentiates the anticataleptic action of clonidine against perphenazine-induced catalepsy in rats. ( Garg, SK; Kulkarni, SK; Shukla, VK, 1986) |
| "Quipazine-treated animals required more elicitation attempts before displaying TI." | 1.26 | Tonic immobility in domestic fowl: anticataleptic effects of quipazine. ( Wallnau, LB, 1980) |
| "Fenfluramine, which promotes 5-HT release, also reduced TI duration." | 1.26 | The effects of tryptophan and manipulations of serotonergic receptors on tonic immobility in chickens. ( Bordash, GD; Corso, P; Wallnau, LB, 1981) |
| "Pretreatment with quipazine, a serotonin agonist, and clomipramine, a selective serotonin neuronal uptake blocker, was found to potentiate the cataleptic effect of haloperidol in a dose-dependent manner in rats." | 1.26 | Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. ( Balsara, JJ; Chandorkar, AG; Jadhav, JH, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rasmussen, K | 1 |
| Benvenga, MJ | 1 |
| Bymaster, FP | 1 |
| Calligaro, DO | 1 |
| Cohen, IR | 1 |
| Falcone, JF | 1 |
| Hemrick-Luecke, SK | 1 |
| Martin, FM | 1 |
| Moore, NA | 1 |
| Nisenbaum, LK | 1 |
| Schaus, JM | 1 |
| Sundquist, SJ | 1 |
| Tupper, DE | 1 |
| Wiernicki, TR | 1 |
| Nelson, DL | 1 |
| Malec, D | 1 |
| Langwinski, R | 1 |
| Balsara, JJ | 3 |
| Nandal, NV | 1 |
| Gada, VP | 1 |
| Chandorkar, AG | 3 |
| Wallnau, LB | 2 |
| Bordash, GD | 1 |
| Corso, P | 1 |
| Seeger, TF | 1 |
| Seymour, PA | 1 |
| Schmidt, AW | 1 |
| Zorn, SH | 1 |
| Schulz, DW | 1 |
| Lebel, LA | 1 |
| McLean, S | 1 |
| Guanowsky, V | 1 |
| Howard, HR | 1 |
| Lowe, JA | 1 |
| Jadhav, JH | 2 |
| Muley, MP | 1 |
| Shukla, VK | 1 |
| Garg, SK | 1 |
| Kulkarni, SK | 1 |
9 other studies available for quipazine and Anochlesia
| Article | Year |
|---|---|
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalep | 2005 |
Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
Topics: Analgesics; Animals; Catalepsy; Drug Interactions; Fluoxetine; Humans; Male; Propylamines; Quinoline | 1980 |
Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on molindone-induced catalepsy in the rat.
Topics: Animals; Brain Stem; Catalepsy; Clomipramine; Humans; Indoles; Male; Methysergide; Molindone; Quipaz | 1981 |
Tonic immobility in domestic fowl: anticataleptic effects of quipazine.
Topics: Animals; Catalepsy; Chickens; Haloperidol; Humans; Motor Activity; Quinolines; Quipazine; Stereotype | 1980 |
The effects of tryptophan and manipulations of serotonergic receptors on tonic immobility in chickens.
Topics: Animals; Catalepsy; Chickens; Cinanserin; Fenfluramine; Humans; Immobilization; p-Chloroamphetamine; | 1981 |
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Biogen | 1995 |
Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on morphine-induced catalepsy in the rat.
Topics: Animals; Catalepsy; Central Nervous System; Clomipramine; Drug Interactions; Humans; Male; Methyserg | 1979 |
Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.
Topics: Animals; Catalepsy; Central Nervous System; Clomipramine; Drug Interactions; Haloperidol; Humans; Ma | 1979 |
Yohimbine potentiates the anticataleptic action of clonidine against perphenazine-induced catalepsy in rats.
Topics: Animals; Catalepsy; Clonidine; Drug Synergism; Male; Perphenazine; Quipazine; Rats; Rats, Inbred Str | 1986 |